Alzheimer's Disease Trial, Recruiting NCT07025070 Sponsor: Technical University of Madrid Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT07025070
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are former athletes and still do regular physical exercise at a moderate to vigorous level at least 3 days per week (Group A).
  • People who are largely inactive — meaning less than 150 minutes of moderate exercise per week or a low activity score on a standard physical activity questionnaire (Group B).
  • People in either group whose exercise habits or inactive lifestyle have been consistent for at least 6 months before the study assessments take place.
  • People with no history of neurological or psychiatric disorders and no serious medical conditions.

Who may not be able to join:

  • People with medical conditions that carry a high risk of causing thinking or memory problems.
  • People who have had a severe head injury with loss of consciousness in the past 5 years.
  • People who drink more than 3 alcoholic drinks per day.
  • People who regularly use certain medications, including anxiety medications, antipsychotics, opioids, anti-seizure drugs, or sleep sedatives.
  • People with hearing or vision problems significant enough to interfere with the study tests.
  • People with a history of a brain or nervous system disease that meaningfully affects thinking or memory — for example, a history of stroke (confirm with trial site).
  • People with certain brain abnormalities found incidentally that could affect thinking ability or life expectancy — for example, a malignant brain tumour.
  • People with a severe ongoing illness — for example, cancer currently under treatment.
  • People who use anabolic substances (such as performance-enhancing drugs).
  • People who have difficulty understanding spoken or written Spanish.
  • People with pacemakers or metal implants that could interfere with an MRI scan.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +34 663002621

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Technical University of Madrid
Registry
ClinicalTrials.gov
Start date
25 November 2024
Est. completion
1 January 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Concentration of brain-derived neurotrophic factor (BDNF) in plasma (pg/mL); Concentration of total tau protein in plasma (pg/mL); Hippocampal volume measured by high-resolution 3 T T1-weighted MRI (mm³); Resting-state functional connectivity between primary motor cortex and supplementary motor area measured by 3 T fMRI (Fisher-Z); Digit Span Forward maximum span length (digits); Trail Making Test Part A completion time (seconds); Digit Span Backward maximum span length (digits); Trail Making Test Part B completion time (seconds); Verbal fluency (F-A-S) total words in 60 s (count); Stroop Colo...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov